Dr. Daniel Amen shares his BRIGHTMINDS approach for preventing Alzheimer's, addressing 11 risk factors including blood flow, ...

Alzheimer’s disease continues to rise as one of the most pressing health challenges facing aging populations today. It ...

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA approves a ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a ...

People in early stages of the disease may show other signs of cognitive deterioration such as being unable to follow ...

UCLA Health researchers mapped four distinct pathways leading to Alzheimer’s disease using electronic health records.   The ...

Researchers reveal four distinct sequences of health conditions that commonly lead to Alzheimer’s, offering new hope for ...

Frontotemporal dementia or frontotemporal degeneration (FTD) refers to a range of disorders that impact the brain’s frontal ...

Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for ...

A neglected piece of the Alzheimer's puzzle has been getting increased scientific attention: why women are twice as likely as ...

Tuesday night, the Alzheimer’s Association hosted a kick-off party for the annual “Walk to End Alzheimer’s”. The 2-mile walk, ...